Cargando…
Tumor-infiltrating lymphocytes, breast cancer subtypes and therapeutic efficacy
By analyzing over 2000 samples from a randomized clinical trial, we have recently associated high levels of tumor-infiltrating lymphocytes with an excellent prognosis among triple negative breast cancer patients as well with improved clinical responses to immunogenic chemotherapy among patients bear...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Landes Bioscience
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782009/ https://www.ncbi.nlm.nih.gov/pubmed/24073365 http://dx.doi.org/10.4161/onci.24720 |